About Us

Our Mission

At iCura Diagnostics, we are revolutionizing the contract research organization (CRO) landscape by redefining the way laboratory testing and research services are delivered. Our mission is to provide agile, client-centric solutions that empower our partners to accelerate their precision medicine initiatives and bring life-saving therapies to patients faster.

Agility and Expertise

To avoid hierarchical structures that can slow down decision-making and hinder project execution, we have implemented a flat organizational structure. Our agile teams, comprised of experts and laboratory professionals, excel in the entire service life cycle. From initial client engagement and scientific discussions to cost analysis, contract finalization, compliance, data transfer, and billing, we ensure efficient project management and faster turnaround times. We understand the importance of timely execution, particularly for time-sensitive projects.

Specialized Laboratory Testing Solutions

iCura Diagnostics is dedicated to providing specialized laboratory testing solutions tailored to the unique needs of our clients. We specialize in emerging technologies and advanced laboratory testing solutions in areas crucial for new treatment development and validation, including immune-therapy, cell and gene therapy, spatial biology, tumor microenvironment, organoid culture systems, and more. Our teams of MD pathologists and PhD scientists bring extensive industrial experience, enabling effective communication and a deep understanding of our clients’ requirements.

Navigating the Dynamic World of Laboratory Testing

In the rapidly evolving field of precision medicine, professionals face the challenge of staying abreast of emerging laboratory testing platforms and technologies. At iCura, we understand the uncertainties and complexities associated with choosing the right test, platform, or brand, understanding costs, interpreting data output, and addressing regulatory and compliance concerns.

As a vendor-agnostic CRO, our core mission is to help clients identify the most suitable laboratory testing platforms in a timely and cost-effective manner. Leveraging years of experience, we provide valuable insights into the strengths and limitations of each laboratory testing platform, particularly in the context of emerging tests. Our expertise ensures that our clients can make informed decisions, select the most suitable testing platforms, and advance their research goals confidently.

Streamlining Regulatory Compliance

Navigating regulatory requirements is a crucial aspect of laboratory testing for clinical trials. The distinctions between pre-clinical and clinical phases, as well as the numerous regulatory guidelines and authorities, can be overwhelming. At iCura, we understand these challenges and offer comprehensive support from highly experienced experts.

From the planning phase of your trials or studies, our team provides peace of mind. We collaborate closely with our clients, offering guidance and assistance to ensure comprehensive understanding and compliance with regulatory requirements. With iCura as your partner, you can approach your lab testing endeavors with certainty, knowing that you have the support needed to navigate the complexities of regulatory compliance.

Comprehensive Ancillary Support

We recognize the significance of effective sample management, transportation, lab manuals, and collection site training in ensuring the success of clinical trials and translational studies. At iCura, we prioritize these ancillary aspects to ensure seamless execution and reliable data generation.

Drawing on our extensive experience in lab testing and sample management, we have developed streamlined processes and protocols. These processes guarantee the smooth handling and transportation of samples, while our detailed lab manuals provide clear instructions for optimal data generation and analysis. Additionally, our comprehensive training programs for collection sites equip personnel with the necessary knowledge and skills.

With our comprehensive ancillary support services, we aim to provide our clients with the assurance and peace of mind necessary for the successful execution of their clinical trials or translational studies.

Partner with iCura Diagnostics and experience the difference of a client-centric approach, expert guidance, and efficient project execution. Together, let’s drive innovation, accelerate scientific discovery, and transform the future of laboratory testing. Contact us today to discuss how iCura Diagnostics can empower your research and propel your projects forward.

experience excellence

Digital Pathology/ Liquid Biopsy

Our Board Certified Pathologists and Laboratory Scientists have decades of experience in Molecular and Cellular Pathology, Immunology, Hematology, and Informatics. We cover specialties in Anatomic Pathology, Clinical Pathology, Hematology, as well as Clinical Informatics, with a focused interest in Digital Pathology, Histopathology, Immuno-Oncology, and Oncology testing in general. The team has successfully led an intended use validation process of a digital pathology system in a major regional healthcare system. Our research and practice experiences has a strong focus on the applications of Digital Pathology in clinical research and medical diagnostics. 

experience Excellence

Digital Pathology/ Liquid Biopsy ​

Our Board Certified Pathologists and Laboratory Scientists have decades of experience in Molecular and Cellular Pathology, Immunology, Hematology, and Informatics. We cover specialties in Anatomic Pathology, Clinical Pathology, Hematology, as well as Clinical Informatics, with a focused interest in Digital Pathology, Histopathology, Immuno-Oncology, and Oncology testing in general. The team has successfully led an intended use validation process of a digital pathology system in a major regional healthcare system. Our research and practice experiences has a strong focus on the applications of Digital Pathology in clinical research and medical diagnostics.

OUR FOCUS

Push forward the availability of Liquid Biopsy

Our other focus is to push forward the availability of Liquid Biopsy tests to our patients and drug development industry. The analysis of circulating tumor cells and DNAs is emerging as a powerful tool for Oncology research and patient management. We are dedicated to provide this tool to a larger pool of researchers and healthcare providers.

OUR FOCUS

Push forward the availability of Liquid Biopsy

Our other focus is to push forward the availability of Liquid Biopsy tests to our patients and drug development industry. The analysis of circulating tumor cells and DNAs is emerging as a powerful tool for Oncology research and patient management. We are dedicated to provide this tool to a larger pool of researchers and healthcare providers.

OUR FOCUS

Push forward the availability of Liquid Biopsy​

Our other focus is to push forward the availability of Liquid Biopsy tests to our patients and drug development industry. The analysis of circulating tumor cells and DNAs is emerging as a powerful tool for Oncology research and patient management. We are dedicated to provide this tool to a larger pool of researchers and healthcare providers.

Laboratory Accreditation and Test Validation

Our Board Certified Pathologists and laboratories operational professionals have years of experience in clinical laboratory accreditation and test validation. We have successfully helped many labs in obtaining accreditation and Covid-19 test validation recently.

Licensures

Our pathologists currently hold active licenses to practice as a physician/pathologist in the states of Pennsylvania, New York, and New Jersey.

Laboratory Accreditation and Test Validation

Our Board Certified Pathologists and laboratories operational professionals have years of experience in clinical laboratory accreditation and test validation. We have successfully helped many labs in obtaining accreditation and Covid-19 test validation recently.

Licensures

Our pathologists currently hold active licenses to practice as a physician/pathologist in the states of Pennsylvania, New York, and New Jersey.

GLP, CAP, CLIA Compliant Laboratory for Lab Tests in Clinical Trial, Oncology Research, and Patient Management

CLIA ID: 39D2227338

CAP #: 9116195

Pennsylvania Lab Permit: 38827